A Severe Dementia Case in End of Life Care with Psychiatric Symptoms Treated by Perampanel
Asaki Kumamoto, Yuhei Chiba, Akira Suda, Akitoyo Hishimoto, Akihiko Kase
J Epilepsy Res. 2021;11(1):93-95. Published online 2021 Jun 30 DOI: https://doi.org/10.14581/jer.21012
Citations to this article as recorded by 
Hyperammonaemia disrupts daily rhythms reversibly by elevating glutamate in the central circadian pacemaker
Daniel GranadosâFuentes, Kevin Cho, Gary J. Patti, Rodolfo Costa, Erik D. Herzog, Sara Montagnese
Liver International.2023; 43(3): 673. CrossRef
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy
Fabio Perversi, Cinzia Costa, Angelo Labate, Simona Lattanzi, Claudio Liguori, Marta Maschio, Stefano Meletti, Lino Nobili, Francesca Felicia Operto, Andrea Romigi, Emilio Russo, Carlo Di Bonaventura
Frontiers in Neurology.2023;[Epub] CrossRef
Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model
Leanne M. Lehmann, Melissa Barker-Haliski
Frontiers in Neurology.2023;[Epub] CrossRef